pbf-677
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2015 (NCT02639975)
Timeline
Indications
Mechanism of action
- Adenosine A3 receptorANTAGONIST
ADORA3 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pbf-677
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03773952 | Phase 2 | Jul 1, 2018 | Paloma Pharmaceuticals, Inc., QualitecFarma |
| NCT02639975 | Phase 1 | Dec 1, 2015 | Paloma Pharmaceuticals, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Paloma Pharmaceuticals, Inc. | For profit | 2 | 2 | 2 | 2015 |
| QualitecFarma | For profit | 1 | 0 | 1 | 2018 |
2 organizations
Page 1 / 1